Key facts
- Boots said the service is for UK patients aged 25 and older with an eligible condition such as chronic pain, anxiety or insomnia.
- Boots said patients must first have tried conventional treatments without success before being prescribed medical cannabis.
- Boots said prescriptions would be independently reviewed by a multidisciplinary clinical team including a second consultant.
Boots announced on Monday that it will begin prescribing medical cannabis, a first for a UK high street pharmacy. The online service, called SureLeaf, is offered to patients in the UK aged 25 and older who have an eligible condition such as chronic pain, anxiety or insomnia.
Patients will be invited to start an assessment online. Their suitability will then be reviewed by a clinical team before they are invited to a video consultation with a consultant, according to Boots. Boots said any prescription would be "independently reviewed by a multidisciplinary clinical team that includes a second, independent consultant, before treatment begins". It said patients must first have tried conventional treatments without success and would be regularly reviewed.
Boots is launching SureLeaf alongside a collaborative research programme with the University of Nottingham that will examine patient outcomes, prescribing practices and experience in the treatment of chronic pain.
Boots' chief healthcare officer, Jamie Kerruish, said: "Millions of people live with ongoing pain and, for some, conventional treatments do not provide adequate symptom relief." Dr David Gwynne, the medical director of Boots' online service, said: "Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis."
The prescription of cannabis-derived medicines was legalised in 2018. Many private clinics have been treating patients with them for years. Only people with rare forms of epilepsy, certain side-effects of chemotherapy and certain multiple sclerosis symptoms can get it on the NHS.